W
Wade L. Thorstad
Researcher at Washington University in St. Louis
Publications - 186
Citations - 10362
Wade L. Thorstad is an academic researcher from Washington University in St. Louis. The author has contributed to research in topics: Radiation therapy & Cancer. The author has an hindex of 42, co-authored 170 publications receiving 8472 citations. Previous affiliations of Wade L. Thorstad include University of Washington & Memorial Sloan Kettering Cancer Center.
Papers
More filters
Journal ArticleDOI
Long-Term Results of RTOG 91-11: A Comparison of Three Nonsurgical Treatment Strategies to Preserve the Larynx in Patients With Locally Advanced Larynx Cancer
Arlene A. Forastiere,Qiang Zhang,Randal S. Weber,Moshe H. Maor,Helmuth Goepfert,Thomas F. Pajak,William H. Morrison,Bonnie S. Glisson,Andy Trotti,John A. Ridge,Wade L. Thorstad,Henry N. Wagner,John F. Ensley,Jay S. Cooper +13 more
TL;DR: These 10-year results show that induction PF followed by RT and concomitant cisplatin/RT show similar efficacy for the composite end point of LFS, and new strategies that improve organ preservation and function with less morbidity are needed.
Journal ArticleDOI
Randomized Phase III Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Stage III to IV Head and Neck Carcinoma: RTOG 0522
K. Kian Ang,Qiang Zhang,David I. Rosenthal,Phuc Felix Nguyen-Tan,Eric J. Sherman,Randal S. Weber,James M. Galvin,James A. Bonner,Jonathan Harris,Adel K. El-Naggar,Maura L. Gillison,Richard C.K. Jordan,Andre Konski,Wade L. Thorstad,Andy Trotti,Jonathan J. Beitler,Adam S. Garden,William J. Spanos,Sue S. Yom,Rita Axelrod +19 more
TL;DR: Adding cetuximab to radiation-cisplatin did not improve outcome and hence should not be prescribed routinely, and the PFS and OS were higher in patients with p16-positive OPC, but outcomes did not differ by EGFR expression.
Journal Article
Common Terminology Criteria for Adverse Events (CTCAE) v4.0 Based Hybrid Patient and Physician Quest
Pawel Dyk,Joseph O. Deasy,Daniel G. Mullen,L. Eschen,H. Pope,Todd A. DeWees,Wade L. Thorstad +6 more
Journal ArticleDOI
Intensity-Modulated Radiation Therapy With or Without Chemotherapy for Nasopharyngeal Carcinoma: Radiation Therapy Oncology Group Phase II Trial 0225
Nancy Y. Lee,Jonathan Harris,Adam S. Garden,William L. Straube,Bonnie S. Glisson,Ping Xia,Walter R. Bosch,William H. Morrison,Jeanne M. Quivey,Wade L. Thorstad,Chris Jones,K. Kian Ang +11 more
TL;DR: It was feasible to transport IMRT with or without chemotherapy in the treatment of NPC to a multi-institutional setting with 90% LRPF rate reproducing excellent reports from single institutions.
Journal ArticleDOI
Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer.
Jeffrey D. Bradley,Wade L. Thorstad,Sasa Mutic,Tom R. Miller,Farrokh Dehdashti,Barry A. Siegel,Walter R. Bosch,Rudi J. Bertrand +7 more
TL;DR: Radiation targeting with fused FDG-PET and CT images resulted in alterations in radiation therapy planning in over 50% of patients by comparison with CT targeting.